What are the best treatments for Familial Hypercholesterolemia?

TL;DR: Treatment for Familial Hypercholesterolemia (FH) centers on aggressive LDL cholesterol reduction through high-intensity statins, often combined with ezetimibe and PCSK9 inhibitors. Because Familial Hypercholesterolemia is a genetic condition, lifelong management is essential to prevent premature cardiovascular disease and requires a highly personalized approach tailored by a lipid specialist.

What are the primary medical treatments for Familial Hypercholesterolemia?

The cornerstone of managing Familial Hypercholesterolemia is pharmacological intervention to lower LDL cholesterol levels significantly. Most clinical guidelines recommend the following combination therapies:

• Statins: High-intensity statins (such as atorvastatin or rosuvastatin) are the first-line therapy to inhibit cholesterol synthesis in the liver.


• Ezetimibe (Zetia): Often added to statin therapy to further block cholesterol absorption in the intestines.


• PCSK9 Inhibitors: Injectable medications (such as evolocumab or alirocumab) that drastically lower LDL levels for patients with Familial Hypercholesterolemia who do not reach target levels with oral meds.


• Bile acid sequestrants: Used as adjunctive therapy to help remove cholesterol from the body.

Are there non-pharmacological interventions for Familial Hypercholesterolemia?

While medication is critical, lifestyle modifications are vital for overall cardiovascular health in patients with Familial Hypercholesterolemia. This includes a heart-healthy diet low in saturated fats and regular aerobic exercise. For patients with severe, homozygous Familial Hypercholesterolemia, LDL apheresis—a procedure similar to dialysis that mechanically filters LDL cholesterol from the blood—may be required on a bi-weekly basis.

Which specialists should be on my care team?

Managing Familial Hypercholesterolemia requires a multidisciplinary approach. Your care team should ideally include a lipidologist (a specialist in cholesterol disorders), a cardiologist, and a genetic counselor to discuss family screening. Currently, 14 members of the DiseaseMaps.org community are navigating these care teams and sharing their experiences with Familial Hypercholesterolemia.

Are there emerging treatments for Familial Hypercholesterolemia?

Research is rapidly evolving, with new therapies like bempedoic acid and inclisiran—a small interfering RNA (siRNA) therapy—offering new options for those who struggle with traditional Familial Hypercholesterolemia treatments. Clinical trials are also exploring gene-editing technologies to address the root genetic cause of Familial Hypercholesterolemia.

Next steps

• Consult a board-certified lipidologist to discuss your specific lipid profile.


• Request a referral for genetic testing to confirm your specific mutation.


• Join the DiseaseMaps.org community to connect with others managing Familial Hypercholesterolemia.


• Review clinical trial opportunities on ClinicalTrials.gov.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice; please consult your physician before making any changes to your treatment plan.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Familial Hypercholesterolemia


• Orphanet: Familial Hypercholesterolemia (ORPHA:436)


• The FH Foundation: Guidelines for Patients and Caregivers


• OMIM: Hypercholesterolemia, Familial (143890)